To include your compound in the COVID-19 Resource Center, submit it here.

BioCanCell reports Phase I/IIa data for BC-819 in bladder cancer

BioCanCell Ltd. (Tel Aviv:BICL) reported final data from a Phase I/IIa trial in 38 patients with resected, early stage

Read the full 199 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE